Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis - Concepedia

Concepedia

Publication | Open Access

Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis

DOI Full Paper Access

612

Citations

29

References

2011

Year

Philippe Gevaert, Nicholas Van Bruaene, Tom Cattaert, Kristel Van Steen, Thibaut Van Zele, Frederic Acke, Natalie De Ruyck, Katrien Blomme, Ana R. Sousa, Richard P. Marshall,

Journal of Allergy and Clinical Immunology

Clinical ImmunologyAutoimmune DiseaseHumanized Anti–il-5 MabImmunodeficienciesSevere Nasal PolyposisImmunologyTreatment OptionAutoimmunityImmunologic DiseaseAllergic RhinitisImmunotherapyMedicine

References

	Year	Citations

Page 1

Page 1